Your browser doesn't support javascript.
loading
Acute exacerbations in children's interstitial lung disease.
Seidl, Elias; Schwerk, Nicolaus; Carlens, Julia; Wetzke, Martin; Emiralioglu, Nagehan; Kiper, Nural; Lange, Joanna; Krenke, Katarzyna; Szepfalusi, Zsolt; Stehling, Florian; Baden, Winfried; Hämmerling, Susanne; Jerkic, Silvija-Pera; Proesmans, Marijke; Ullmann, Nicola; Buchvald, Frederik; Knoflach, Katrin; Kappler, Matthias; Griese, Matthias.
Afiliação
  • Seidl E; Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, German Center for Lung Research, Munich, Germany.
  • Schwerk N; Clinic for Pediatric Pneumology, Allergology, and Neonatology, Hannover Medical School, German Center for Lung Research, Hannover, Germany.
  • Carlens J; Clinic for Pediatric Pneumology, Allergology, and Neonatology, Hannover Medical School, German Center for Lung Research, Hannover, Germany.
  • Wetzke M; Clinic for Pediatric Pneumology, Allergology, and Neonatology, Hannover Medical School, German Center for Lung Research, Hannover, Germany.
  • Emiralioglu N; Division of Pediatric Pulmonology, Hacettepe University Faculty of Medicine, Ankara, Turkey, Ankara, Turkey.
  • Kiper N; Division of Pediatric Pulmonology, Hacettepe University Faculty of Medicine, Ankara, Turkey, Ankara, Turkey.
  • Lange J; Department of Pediatric Pneumology and Allergy, Medical University of Warsaw, Warsaw, Poland.
  • Krenke K; Department of Pediatric Pneumology and Allergy, Medical University of Warsaw, Warsaw, Poland.
  • Szepfalusi Z; Division of Pediatric Pulmonology, Allergy and Endocrinology, Departement of Pediatrics and Adolescent Medicine, Comprehensive Center of Pediatrics, Medical University of Vienna, Vienna, Austria.
  • Stehling F; Department of Pediatric Pulmonology and Sleep Medicine, University Children's Hospital Essen, Essen, Germany.
  • Baden W; Department of Pediatrics 2, Children's Hospital, Eberhard Karls University, Tuebingen, Germany.
  • Hämmerling S; Division of Pediatric Pulmonology & Allergy and Cystic Fibrosis Center, Department of Pediatrics III, University of Heidelberg, Germany, Heidelberg, Germany.
  • Jerkic SP; Department of Allergy, Pneumology, and Cystic Fibrosis, Goethe University Frankfurt am Main, Frankfurt, Germany.
  • Proesmans M; Department of Pediatrics, Pediatric Pulmonology, University Hospital of Leuven, Leuven, Flanders, Belgium.
  • Ullmann N; Pediatric Pulmonology and Respiratory Intermediate Care Unit, Sleep and Long Term Ventilation Unit, Academic Department of Pediatrics (DPUO), Pediatric Hospital "Bambino Gesù" Research Institute, Roma, Italy.
  • Buchvald F; Department of Paediatrics and Adolescent Medicine, Paediatric Pulmonary Service, Copenhagen University Hospital, Rigshospitalet, Danish PCD & chILD Centre, CF Centre Copenhagen, Copenhagen, Denmark.
  • Knoflach K; Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, German Center for Lung Research, Munich, Germany.
  • Kappler M; Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, German Center for Lung Research, Munich, Germany.
  • Griese M; Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, German Center for Lung Research, Munich, Germany matthias.griese@med.uni-muenchen.de.
Thorax ; 77(8): 799-804, 2022 08.
Article em En | MEDLINE | ID: mdl-35149584
ABSTRACT

INTRODUCTION:

Acute exacerbations (AEs) increase morbidity and mortality of patients with chronic pulmonary diseases. Little is known about the characteristics and impact of AEs on children's interstitial lung disease (chILD).

METHODS:

The Kids Lung Register collected data on AEs, the clinical course and quality of life (patient-reported outcomes - PRO) of rare paediatric lung diseases. Characteristics of AEs were obtained.

RESULTS:

Data of 2822 AEs and 2887 register visits of 719 patients with chILD were recorded. AEs were characterised by increased levels of dyspnoea (74.1%), increased respiratory rate (58.6%) and increased oxygen demand (57.4%). Mostly, infections (94.4%) were suspected causing an AE. AEs between two register visits revealed a decline in predicted FEV1 (median -1.6%, IQR -8.0 to 3.9; p=0.001), predicted FVC (median -1.8%, IQR -7.5 to 3.9; p=0.004), chILD-specific questionnaire (median -1.3%, IQR -3.6 to 4.5; p=0.034) and the physical health summary score (median -3.1%, IQR -15.6 to 4.3; p=0.005) compared with no AEs in between visits. During the median observational period of 2.5 years (IQR 1.2-4.6), 81 patients died. For 49 of these patients (60.5%), mortality was associated with an AE.

CONCLUSION:

This is the first comprehensive study analysing the characteristics and impact on the clinical course of AEs in chILD. AEs have a significant and deleterious effect on the clinical course and health-related quality of life in chILD.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Doenças Pulmonares Intersticiais Tipo de estudo: Prognostic_studies Limite: Child / Humans Idioma: En Revista: Thorax Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Doenças Pulmonares Intersticiais Tipo de estudo: Prognostic_studies Limite: Child / Humans Idioma: En Revista: Thorax Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha